Last reviewed · How we verify

NCT03903328

Prevalence of Sarcopenia Among Elderly Living in Care Facilities in Klang Valley, Malaysia

Completed Last updated 4 April 2019
What this trial tests

trial testing Sarcopenia assessment in Sarcopenia in 205 participants. Completed in 4 December 2017.

Timeline
6 December 2016
Primary endpoint
4 December 2017
4 December 2017

Quick facts

Lead sponsorUniversiti Tunku Abdul Rahman
StatusCompleted
Study typeOBSERVATIONAL
Enrollment205
Start date6 December 2016
Primary completion4 December 2017
Estimated completion4 December 2017

Drugs / interventions tested

Conditions studied

Sponsor

Universiti Tunku Abdul Rahman

Who can join

60 and older, any sex, with Sarcopenia or Sarcopenic Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study was to investigate the prevalence of age-related progressive decline in muscle mass and strength (Sarcopenia) among Malaysian elderly residing in long-term care facilities. It is a very important condition to study as it is associated with high incidence of fall, hospitalization and mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Universiti Tunku Abdul Rahman trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03903328.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing